Common Contracts
5 similar Confirmatory Offer Letter contracts by Electra Therapeutics, Inc.
August 20, 2026 Chris Clark, C.F.A. Re: Confirmatory Offer Letter Dear Mr. Clark,Confirmatory Offer Letter • August 28th, 2026 • Electra Therapeutics, Inc. • Biological products, (no disgnostic substances)
You are currently employed by Electra Therapeutics, Inc. (the “Company”) as Chief Financial Officer. This letter agreement (“Agreement”) confirms the existing terms and conditions of your continuing employment in that role. This Agreement is contingent and shall only be effective immediately prior to such time as the U.S. Securities and Exchange Commission declares the Company’s registration statement on Form S-1 for its initial public offering effective (such date, the “Effective Date”).
August 20, 2026 Kim-Hien Dao, D.O., Ph.D. Re: Confirmatory Offer Letter Dear Dr. Dao,Confirmatory Offer Letter • August 28th, 2026 • Electra Therapeutics, Inc. • Biological products, (no disgnostic substances)
You are currently employed by Electra Therapeutics, Inc. (the “Company”) as Chief Medical Officer. This letter agreement (“Agreement”) confirms the existing terms and conditions of your continuing employment in that role. This Agreement is contingent and shall only be effective immediately prior to such time as the U.S. Securities and Exchange Commission declares the Company’s registration statement on Form S-1 for its initial public offering effective (such date, the “Effective Date”).
August 20, 2026 Quehuong (Kathy) Dong, Pharm.D., M.B.A. Re: Confirmatory Offer Letter Dear Dr. Dong,Confirmatory Offer Letter • August 28th, 2026 • Electra Therapeutics, Inc. • Biological products, (no disgnostic substances)
You are currently employed by Electra Therapeutics, Inc. (the “Company”) as President and Chief Executive Officer. This letter agreement (“Agreement”) confirms the existing terms and conditions of your continuing employment in that role. This Agreement is contingent and shall only be effective immediately prior to such time as the U.S. Securities and Exchange Commission declares the Company’s registration statement on Form S-1 for its initial public offering effective (such date, the “Effective Date”).
August 20, 2026 Gary S. Koe, Ph.D. Re: Confirmatory Offer Letter Dear Dr. Koe,Confirmatory Offer Letter • August 28th, 2026 • Electra Therapeutics, Inc. • Biological products, (no disgnostic substances)
You are currently employed by Electra Therapeutics, Inc. (the “Company”) as Chief Technical Officer. This letter agreement (“Agreement”) confirms the existing terms and conditions of your continuing employment in that role. This Agreement is contingent and shall only be effective immediately prior to such time as the U.S. Securities and Exchange Commission declares the Company’s registration statement on Form S-1 for its initial public offering effective (such date, the “Effective Date”).
August 20, 2026 Graham Parry, Ph.D. Re: Confirmatory Offer Letter Dear Dr. Parry,Confirmatory Offer Letter • August 28th, 2026 • Electra Therapeutics, Inc. • Biological products, (no disgnostic substances)
You are currently employed by Electra Therapeutics, Inc. (the “Company”) as Chief Scientific Officer. This letter agreement (“Agreement”) confirms the existing terms and conditions of your continuing employment in that role. This Agreement is contingent and shall only be effective immediately prior to such time as the U.S. Securities and Exchange Commission declares the Company’s registration statement on Form S-1 for its initial public offering effective (such date, the “Effective Date”).